Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor
go back to main search page
Accession:CHEBI:76835 term browser browse the term
Definition:An EC 1.1.* (oxidoreductase acting on donor CH-OH group) inhibitor that uses NAD(+) or NADP(+) as acceptor (EC 1.1.1.*).
Synonyms:related_synonym: EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+)acceptor) inhibitors;   EC 1.1.1.* inhibitor;   EC 1.1.1.* inhibitors


show annotations for term's descendants       view all columns           Sort by:
 





Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19679
    role 19623
      biological role 19621
        biochemical role 19147
          enzyme inhibitor 17984
            EC 1.* (oxidoreductase) inhibitor 16370
              EC 1.1.* (oxidoreductase acting on donor CH-OH group) inhibitor 4525
                EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor 2585
                  EC 1.1.1.1 (alcohol dehydrogenase) inhibitor + 29
                  EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitor + 202
                  EC 1.1.1.146 (11beta-hydroxysteroid dehydrogenase) inhibitor + 1
                  EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor + 33
                  EC 1.1.1.159 (7alpha-hydroxysteroid dehydrogenase) inhibitor + 0
                  EC 1.1.1.170 [3beta-hydroxysteroid-4alpha-carboxylate 3-dehydrogenase (decarboxylating)] inhibitor + 0
                  EC 1.1.1.184 [carbonyl reductase (NADPH)] inhibitor + 257
                  EC 1.1.1.188 (prostaglandin-F synthase) inhibitor + 649
                  EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor + 499
                  EC 1.1.1.205 (IMP dehydrogenase) inhibitor + 908
                  EC 1.1.1.21 (aldehyde reductase) inhibitor + 1152
                  EC 1.1.1.210 [3beta(or 20alpha)-hydroxysteroid dehydrogenase] inhibitor + 10
                  EC 1.1.1.25 (shikimate dehydrogenase) inhibitor + 1031
                  EC 1.1.1.267 (1-deoxy-D-xylulose-5-phosphate reductoisomerase) inhibitor + 0
                  EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor + 970
                  EC 1.1.1.37 (malate dehydrogenase) inhibitor + 0
                  EC 1.1.1.44 (NADP(+)-dependent decarboxylating phosphogluconate dehydrogenase) inhibitor + 13
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.